Drug repurposing for cancer treatments: a well-intentioned, but misguided strategy - 02/09/20
Doi : 10.1016/S1470-2045(20)30424-1
Audrey A Tran a, Vinay Prasad b 
a School of Medicine and Division of Hematology Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
b Department of Medicine and Department of Epidemiology and Biostatistics, University of California San Francisco, San Fransisco, CA 94158, USA
El texto completo de este artículo está disponible en PDF.
© 2020
Elsevier Ltd. Reservados todos los derechos.© 2020
Tek Image/Science Photo Library. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 21 - N° 9
P. 1134-1136 - septembre 2020 Regresar al número
Artículo precedente
- Carboplatin plus etoposide or topotecan for small-cell lung cancer
- Oscar Arrieta, Luis Lara-Mejía, Zyanya Lucia Zatarain-Barrón
- Open notes in cancer care: coming soon to patients
- Charlotte Blease, Liz Salmi, Catherine M DesRoches
¿Ya suscrito a @@106933@@ revista ?